| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.46 | 0.004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |